Skip to content
PubMed This is a summary of 53 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 53 referenced papers

Top Authors

Bodo Grimbacher
University of Freiburg
Manfred Fliegauf
University of Freiburg
Leif G. Hanitsch
Humboldt-Universität zu Berlin
Faranaz Atschekzei
Medizinische Hochschule Hannover
Rohan Ameratunga
University of Auckland
Stephen R.A. Jolles
University Hospital of Wales
Hilary J Longhurst
University of Auckland
Siobhan Oisin Burns
Royal Free London NHS Foundation Trust
Reinhold Ernst Schmidt
Medizinische Hochschule Hannover
Kaan Boztuǧ
Austrian Academy of Sciences

Top Institutions

Ranked by publications Top 10 institutions
07

Austrian Academy of Sciences

Vienna, Austria

10 papers

References

References (53)
  1. 1

    Haploinsufficiency of the NF-κB1 Subunit p50 in Common Variable Immunodeficiency.

    Fliegauf M, Bryant VL, Frede N, et al.

    American journal of human genetics 2015; (97(3)):389-403.

    PMID: 26279205
  2. 2

    CVID Associated with Systemic Amyloidosis.

    Esenboga S, Çagdas Ayvaz D, Saglam Ayhan A, et al.

    Case reports in immunology 2015; (2015()):879179 doi:10.1155/2015/879179.

    PMID: 26346511
  3. 3

    Clinical and laboratory correlates of lung disease and cancer in adults with idiopathic hypogammaglobulinaemia.

    Brent J, Guzman D, Bangs C, et al.

    Clinical and experimental immunology 2016; (184(1)):73-82 doi:10.1111/cei.12748.

    PMID: 26646609
  4. 4

    Cellular and humoral influenza-specific immune response upon vaccination in patients with common variable immunodeficiency and unclassified antibody deficiency.

    Hanitsch LG, Löbel M, Mieves JF, et al.

    Vaccine 2016; (34(21)):2417-2423 doi:10.1016/j.vaccine.2016.03.091.

    PMID: 27055021
  5. 5

    NF-κB1 Haploinsufficiency Causing Immunodeficiency and EBV-Driven Lymphoproliferation.

    Boztug H, Hirschmugl T, Holter W, et al.

    Journal of clinical immunology 2016; (36(6)):533-40 doi:10.1007/s10875-016-0306-1.

    PMID: 27338827
  6. 6

    Vaccination in Primary Immunodeficiency Disorders.

    Sobh A, Bonilla FA

    The journal of allergy and clinical immunology. In practice 2016; (4(6)):1066-1075 doi:10.1016/j.jaip.2016.09.012.

    PMID: 27836056
  7. 7

    When to initiate immunoglobulin replacement therapy (IGRT) in antibody deficiency: a practical approach.

    Jolles S, Chapel H, Litzman J

    Clinical and experimental immunology 2017; (188(3)):333-341 doi:10.1111/cei.12915.

    PMID: 28000208
  8. 8

    Clinical Profile, Dosing, and Quality-of-Life Outcomes in Primary Immune Deficiency Patients Treated at Home with Immunoglobulin G: Data from the IDEaL Patient Registry.

    Kearns S, Kristofek L, Bolgar W, et al.

    Journal of managed care & specialty pharmacy 2017; (23(4)):400-406 doi:10.18553/jmcp.2017.23.4.400.

    PMID: 28345437
  9. 9

    Specific Antibody Deficiency: Controversies in Diagnosis and Management.

    Perez E, Bonilla FA, Orange JS, Ballow M

    Frontiers in immunology 2017; (8()):586 doi:10.3389/fimmu.2017.00586.

    PMID: 28588580
  10. 10

    Allogeneic Reduced-Intensity Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease: a Single-Center Prospective Trial.

    Parta M, Kelly C, Kwatemaa N, et al.

    Journal of clinical immunology 2017; (37(6)):548-558 doi:10.1007/s10875-017-0422-6.

    PMID: 28752258
  11. 11

    Influenza Vaccination in Patients with Common Variable Immunodeficiency (CVID).

    Mieves JF, Wittke K, Freitag H, et al.

    Current allergy and asthma reports 2017; (17(11)):78 doi:10.1007/s11882-017-0749-3.

    PMID: 28983790
  12. 12

    Human NF-κB1 Haploinsufficiency and Epstein-Barr Virus-Induced Disease-Molecular Mechanisms and Consequences.

    Hoeger B, Serwas NK, Boztug K

    Frontiers in immunology 2017; (8()):1978 doi:10.3389/fimmu.2017.01978.

    PMID: 29403474
  13. 13

    Loss-of-function nuclear factor κB subunit 1 (NFKB1) variants are the most common monogenic cause of common variable immunodeficiency in Europeans.

    Tuijnenburg P, Lango Allen H, Burns SO, et al.

    The Journal of allergy and clinical immunology 2018; (142(4)):1285-1296 doi:10.1016/j.jaci.2018.01.039.

    PMID: 29477724
  14. 14

    Loss of NF-κB1 Causes Gastric Cancer with Aberrant Inflammation and Expression of Immune Checkpoint Regulators in a STAT-1-Dependent Manner.

    O'Reilly LA, Putoczki TL, Mielke LA, et al.

    Immunity 2018; (48(3)):570-583.e8 doi:10.1016/j.immuni.2018.03.003.

    PMID: 29562203
  15. 15

    Immunosuppressive therapy with rituximab in common variable immunodeficiency.

    Pecoraro A, Crescenzi L, Galdiero MR, et al.

    Clinical and molecular allergy : CMA 2019; (17()):9 doi:10.1186/s12948-019-0113-3.

    PMID: 31080365
  16. 16

    Late-Onset Antibody Deficiency Due to Monoallelic Alterations in NFKB1.

    Schröder C, Sogkas G, Fliegauf M, et al.

    Frontiers in immunology 2019; (10()):2618 doi:10.3389/fimmu.2019.02618.

    PMID: 31803180
  17. 17

    Efficacy of immunoglobulin replacement therapy and azithromycin in severe asthma with antibody deficiency.

    Tiotiu A, Salvator H, Jaussaud R, et al.

    Allergology international : official journal of the Japanese Society of Allergology 2020; (69(2)):215-222 doi:10.1016/j.alit.2019.10.011.

    PMID: 31812484
  18. 18

    Identification of Novel Genetic Variants in CVID Patients With Autoimmunity, Autoinflammation, or Malignancy.

    Christiansen M, Offersen R, Jensen JMB, et al.

    Frontiers in immunology 2019; (10()):3022 doi:10.3389/fimmu.2019.03022.

    PMID: 32047491
  19. 19

    Characterization of the clinical and immunologic phenotype and management of 157 individuals with 56 distinct heterozygous NFKB1 mutations.

    Lorenzini T, Fliegauf M, Klammer N, et al.

    The Journal of allergy and clinical immunology 2020; (146(4)):901-911 doi:10.1016/j.jaci.2019.11.051.

    PMID: 32278790
  20. 20

    A Pathogenic Missense Variant in NFKB1 Causes Common Variable Immunodeficiency Due to Detrimental Protein Damage.

    Fliegauf M, Krüger R, Steiner S, et al.

    Frontiers in immunology 2021; (12()):621503 doi:10.3389/fimmu.2021.621503.

    PMID: 33995346
  21. 21

    Vaccination in PADs.

    Milito C, Soccodato V, Collalti G, et al.

    Vaccines 2021; (9(6)) doi:10.3390/vaccines9060626.

    PMID: 34207916
  22. 22

    Biochemically deleterious human NFKB1 variants underlie an autosomal dominant form of common variable immunodeficiency.

    Li J, Lei WT, Zhang P, et al.

    The Journal of experimental medicine 2021; (218(11)) doi:10.1084/jem.20210566.

    PMID: 34473196
  23. 23

    Defining the Role of Nuclear Factor (NF)-κB p105 Subunit in Human Macrophage by Transcriptomic Analysis of NFKB1 Knockout THP1 Cells.

    Somma D, Kok FO, Kerrigan D, et al.

    Frontiers in immunology 2021; (12()):669906 doi:10.3389/fimmu.2021.669906.

    PMID: 34721373
  24. 24

    Resolving the polygenic aetiology of a late onset combined immune deficiency caused by NFKB1 haploinsufficiency and modified by PIK3R1 and TNFRSF13B variants.

    Hargreaves CE, Dhalla F, Patel AM, et al.

    Clinical immunology (Orlando, Fla.) 2022; (234()):108910 doi:10.1016/j.clim.2021.108910.

    PMID: 34922003
  25. 25

    Vulnerability to Meningococcal Disease in Immunodeficiency Due to a Novel Pathogenic Missense Variant in NFKB1.

    Anim M, Sogkas G, Schmidt G, et al.

    Frontiers in immunology 2021; (12()):767188 doi:10.3389/fimmu.2021.767188.

    PMID: 35003082
  26. 26

    Common Variable Immunodeficiency-Associated Cancers: The Role of Clinical Phenotypes, Immunological and Genetic Factors.

    Bruns L, Panagiota V, von Hardenberg S, et al.

    Frontiers in immunology 2022; (13()):742530 doi:10.3389/fimmu.2022.742530.

    PMID: 35250968
  27. 27

    Haploidentical Stem Cell Transplantation After TCR-αβ+ and CD19+ Cells Depletion In Children With Congenital Non-Malignant Disease.

    Giardino S, Bagnasco F, Falco M, et al.

    Transplantation and cellular therapy 2022; (28(7)):394.e1-394.e9 doi:10.1016/j.jtct.2022.04.002.

    PMID: 35405368
  28. 28

    [Prophylactic and therapeutic management of increased susceptibility to infection in patients with immunodeficiency].

    Hanitsch LG

    Der Internist 2022; (63(5)):484-492 doi:10.1007/s00108-022-01326-8.

    PMID: 35412057
  29. 29

    Common Variable Immunodeficiency and Neurodevelopmental Delay Due to a 13Mb Deletion on Chromosome 4 Including the NFKB1 Gene: A Case Report.

    Franco-Jarava C, Valenzuela I, Riviere JG, et al.

    Frontiers in immunology 2022; (13()):897975 doi:10.3389/fimmu.2022.897975.

    PMID: 35784294
  30. 30

    Detrimental NFKB1 missense variants affecting the Rel-homology domain of p105/p50.

    Fliegauf M, Kinnunen M, Posadas-Cantera S, et al.

    Frontiers in immunology 2022; (13()):965326 doi:10.3389/fimmu.2022.965326.

    PMID: 36105815
  31. 31

    Long-term follow up of families with pathogenic NFKB1 variants reveals incomplete penetrance and frequent inflammatory sequelae.

    Tuovinen EA, Kuismin O, Soikkonen L, et al.

    Clinical immunology (Orlando, Fla.) 2023; (246()):109181 doi:10.1016/j.clim.2022.109181.

    PMID: 36356849
  32. 32

    Antibody and T-cell responses to coronavirus disease 2019 vaccination in common variable immunodeficiency and specific antibody deficiency.

    Rosenthal JA, Papa MP, Sanz M, et al.

    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2023; (130(6)):743-751.e3 doi:10.1016/j.anai.2023.01.025.

    PMID: 36736722
  33. 33

    Evaluation of Psychiatric Symptomatology, Quality of Life, and Caregiver Burden in Mothers and Children with Primary Immunodeficiency.

    Kılıç N, Kaya Ş, Taşçı G, et al.

    Allergologia et immunopathologia 2023; (51(6)):45-53 doi:10.15586/aei.v51i6.927.

    PMID: 37937495
  34. 34

    Common Variable Immunodeficiency.

    Remiker A, Bolling K, Verbsky J

    The Medical clinics of North America 2024; (108(1)):107-121 doi:10.1016/j.mcna.2023.06.012.

    PMID: 37951645
  35. 35

    A large deletion in a non-coding regulatory region leads to NFKB1 haploinsufficiency in two adult siblings.

    Fusaro M, Coustal C, Barnabei L, et al.

    Clinical immunology (Orlando, Fla.) 2024; (261()):110165 doi:10.1016/j.clim.2024.110165.

    PMID: 38423196
  36. 36

    Anxiety in Polish adult patients with inborn errors of immunity: a cross-sectional study.

    Grochowalska K, Ziętkiewicz M, Nowicka-Sauer K, et al.

    Frontiers in psychiatry 2024; (15()):1293935 doi:10.3389/fpsyt.2024.1293935.

    PMID: 38516260
  37. 37

    Truncating NFKB1 variants cause combined NLRP3 inflammasome activation and type I interferon signaling and predispose to necrotizing fasciitis.

    Nurmi K, Silventoinen K, Keskitalo S, et al.

    Cell reports. Medicine 2024; (5(4)):101503 doi:10.1016/j.xcrm.2024.101503.

    PMID: 38593810
  38. 38

    A qualitative study to explore the burden of disease in activated phosphoinositide 3-kinase delta syndrome (APDS).

    Hitchcock I, Skrobanski H, Matter E, et al.

    Orphanet journal of rare diseases 2024; (19(1)):203 doi:10.1186/s13023-024-03215-9.

    PMID: 38760658
  39. 39

    Limitations in the clinical utility of vaccine challenge responses in the evaluation of primary antibody deficiency including Common Variable Immunodeficiency Disorders.

    Ameratunga R, Longhurst H, Leung E, et al.

    Clinical immunology (Orlando, Fla.) 2024; (266()):110320 doi:10.1016/j.clim.2024.110320.

    PMID: 39025346
  40. 40

    Health-related quality of life in patients with inborn errors of immunity: A systematic review and meta-analysis.

    Xiao N, Huang X, Yang D, et al.

    Preventive medicine 2024; (186()):108079 doi:10.1016/j.ypmed.2024.108079.

    PMID: 39053518
  41. 41

    Common Variable Immunodeficiency Clinical Manifestations Are Shaped by Presence and Type of Heterozygous NFKB1 Variants.

    Yin J, Hayes KM, Ong MS, et al.

    The journal of allergy and clinical immunology. In practice 2025; (13(3)):639-646 doi:10.1016/j.jaip.2024.12.002.

    PMID: 39672378
  42. 42

    Genetic Counseling in Pediatric Inborn Errors of Immunity: Perspective Piece on Current Practice and Considerations.

    DeBortoli E, McInerney-Leo A, Macintosh R, et al.

    The journal of allergy and clinical immunology. In practice 2025; (13(8)):1918-1927 doi:10.1016/j.jaip.2025.03.052.

    PMID: 40252833
  43. 43

    Common variable immunodeficiency due to a novel variant in NFKB1 with a neonatal presentation of parechovirus meningitis and sepsis-like illness.

    Szczawińska-Popłonyk A, Popłonyk N, Bernat-Sitarz K, et al.

    Allergologia et immunopathologia 2025; (53(3)):31-40 doi:10.15586/aei.v53i3.1307.

    PMID: 40342112
  44. 44

    "It's a Godsend": Parental experiences of genomic testing for paediatric inborn errors of immunity.

    Clark A, DeBortoli E, Blancoe M, et al.

    European journal of human genetics : EJHG 2025; (33(10)):1342-1349 doi:10.1038/s41431-025-01917-7.

    PMID: 40730688
  45. 45

    The Presentation, Diagnosis, and Management of Autosomal Dominant Common Variable Immunodeficiency Type XII with NFKB1 Mutation and Autoimmune Neutropenia Treated with Allogenic Stem Cell Transplantation.

    Gold M, Kannan C, Schofield A, et al.

    Hematology reports 2025; (17(5)) doi:10.3390/hematolrep17050049.

    PMID: 41148944
  46. 46

    Common Variable Immunodeficiency Disorders: A perspective from New Zealand.

    Ameratunga R, J Longhurst H, Lehnert K, et al.

    Clinical reviews in allergy & immunology 2025; (68(1)):105 doi:10.1007/s12016-025-09099-2.

    PMID: 41324804
  47. 47

    Clinical, genetic, and functional characterization of novel NFKB1 variants in Chinese patients with primary immunodeficiency.

    Zhang J, Cai H, Zhu T, Shen M

    Clinical and experimental immunology 2026; (220(1)) doi:10.1093/cei/uxag033.

    PMID: 42252100
  48. 48

    Patient and caregiver perspectives on transition from pediatric to adult care in inborn errors of immunity: a Polish multicenter survey.

    Będzichowska A, Tomaszewska A, Napiórkowska-Baran K, et al.

    Frontiers in immunology 2026; (17()):1816943 doi:10.3389/fimmu.2026.1816943.

    PMID: 42433362
  49. 49

    Shared Decision-Making and Health-Related Quality of Life in the Diagnosis and Management of Patients With Inborn Errors of Immunity.

    Lawrence MG, Kim VHD, Orange JS, Scherzer R

    The journal of allergy and clinical immunology. In practice 2026; doi:10.1016/j.jaip.2026.07.010.

    PMID: 42447994
  50. 50

    Clinical and immunological characterization of NFKB1 haploinsufficiency in Japan.

    Moriya K, Kamiyama Y, Ogino R, et al.

    Frontiers in immunology 2026; (17()):1866459 doi:10.3389/fimmu.2026.1866459.

    PMID: 42488646
  51. 51

    Multidisciplinary Delphi consensus on malignancy screening in patients with common variable immunodeficiency.

    Cabanero-Navalon MD, de Andrés-Martín A, Gil AA, et al.

    Frontiers in immunology 2026; (17()):1897051 doi:10.3389/fimmu.2026.1897051.

    PMID: 42676356
  52. 52

    Standardized Human Phenotype Ontology annotation enables high-quality phenotypic data capture in a real-world common variable immunodeficiency cohort.

    Campos LC, Favreau É, Greene D, et al.

    The Journal of allergy and clinical immunology 2026; doi:10.1016/j.jaci.2026.08.027.

    PMID: 42767568
  53. 53

    Genotype-phenotype analysis in 333 individuals with heterozygous variants in NFKB1.

    Armbruster SM, Caballero-Oteyza A, Bartsch O, et al.

    Journal of human immunity 2027; (3(1)) doi:10.70962/jhi.20260076.

    PMID: 42895832